Related references
Note: Only part of the references are listed.Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer
Nils D. Arvold et al.
CANCER (2012)
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo
M. M. Vickers et al.
EUROPEAN JOURNAL OF CANCER (2012)
Radiotherapy Technical Considerations in the Management of Locally Advanced Pancreatic Cancer: American-French Consensus Recommendations
Florence Huguet et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
Yousuke Nakai et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
INTRAOPERATIVE RADIOTHERAPY FOR UNRESECTABLE PANCREATIC CANCER: A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF 144 PATIENTS
Kazuhiko Ogawa et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
INDUCTION GEMCITABINE AND STEREOTACTIC BODY RADIOTHERAPY FOR LOCALLY ADVANCED NONMETASTATIC PANCREAS CANCER
Anand Mahadevan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER
Devin Schellenberg et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Preoperative Diabetes Mellitus and Long-Term Survival After Resection of Pancreatic Adenocarcinoma
Carrie K. Chu et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
The Glasgow Prognostic Score Is a Good Predictor of Treatment Outcome in Patients with Unresectable Pancreatic Cancer
Mitsugi Shimoda et al.
CHEMOTHERAPY (2010)
The Impact of Comorbidity on Survival of Danish Colorectal Cancer Patients from 1995 to 2006-A Population-Based Cohort Study
Lene H. Iversen et al.
DISEASES OF THE COLON & RECTUM (2009)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study
B. Chauffert et al.
ANNALS OF ONCOLOGY (2008)
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer
Theresa M. Koppie et al.
CANCER (2008)
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
Sunil Krishnan et al.
CANCER (2007)
Long-term results of Intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer
CG Willett et al.
ANNALS OF SURGERY (2005)
Intraoperative radiation therapy for pancreatic adenocarcinoma - The Komagome Hospital experience
A Okamoto et al.
PANCREAS (2004)
Evaluation of charlson-age comorbidity index as predictor of morbidity and mortality in patients with colorectal carcinoma
JR Ouellette et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2004)
Prognostic importance of Comorbidity in a hospital-based cancer registry
JF Piccirillo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Share Paper
